4//SEC Filing
EPSTEIN ROBERT S 4
Accession 0000950170-25-079712
CIK 0001434316other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:07 PM ET
Size
15.0 KB
Accession
0000950170-25-079712
Insider Transaction Report
Form 4
EPSTEIN ROBERT S
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-29+55,000→ 55,000 totalExercise: $1.32Exp: 2035-05-29→ Common Stock (55,000 underlying)
Footnotes (2)
- [F1]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders.
- [F2]The shares subject to this option shall vest and become exercisable on the earlier of (i) May 29, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001252004
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 4:07 PM ET
- Size
- 15.0 KB